Accordant Advisory Group Inc Bristol Myers Squibb CO Transaction History
Accordant Advisory Group Inc
- $126 Billion
- Q3 2024
A detailed history of Accordant Advisory Group Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Accordant Advisory Group Inc holds 580 shares of BMY stock, worth $33,773. This represents 0.02% of its overall portfolio holdings.
Number of Shares
580
Previous 580
-0.0%
Holding current value
$33,773
Previous $24.1 Million
24.59%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,533Shares Held
1.47BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.24 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.41 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.54 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.55 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $124B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...